GeNeuro SA
GeNeuro SA, a clinical-stage biopharmaceutical company, develops drugs for the treatment of neurodegenerative and autoimmune diseases. The company's lead therapeutic candidate is temelimab, a monoclonal antibody, which has completed Phase IIb clinical tr…
Biotechnology
CH, Plan-les-Ouates [HQ]
Revenue Breakdowns
Segment Analysis Beta
The financial segments are sourced from the SEC' 10-K statement.Revenue By Top Segments
GeNeuro SA can't present it's latest revenue by geo. area
Revenue By Geographic Areas
GeNeuro SA can't present it's latest revenue by geo. area
Historical Revenue By Segment
Last 3Y, in mil. USDGeNeuro SA can't present revenue by segment
Historical Revenue By Geographic Area
Last 3Y, in mil. USDGeNeuro SA can't present revenue by geo. area